Income Statement
AURA BIOSCIENCES, INC.
AURA
Performance Overview
Click any row in the table to add it to this chart
in millions USD
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY |
|---|---|---|---|---|---|
|
Revenue
|
- | - | - | - | - |
|
Cost of Revenue
|
- | - | - | - | - |
|
Gross Profit
|
- | - | - | - | - |
|
Operating Expenses
|
112.79 | 96.12 | 84.99 | 60.30 | 35.25 |
|
Research & Development
|
90.30 | 73.30 | 65.23 | 42.24 | 25.16 |
|
Selling, General & Administrative
|
22.49 | 22.81 | 19.76 | 18.06 | 10.09 |
|
Other Operating Expenses
|
- | - | - | - | - |
|
Operating Income
|
-112.79 | -96.12 | -84.99 | -60.30 | -35.25 |
|
Non-Operating Income
|
6.71 | 9.31 | 8.72 | 1.53 | 0.00 |
|
Interest Income
|
- | - | - | - | - |
|
Interest Expense
|
- | - | - | - | - |
|
Other Non-Op Income / Expense
|
0.08 | -0.12 | -0.08 | -0.01 | - |
|
Income Before Tax
|
-106.08 | -86.81 | -76.27 | - | - |
|
Income Tax Expense
|
0.11 | 0.11 | 0.14 | - | - |
|
Non-Controlling Interest
|
- | - | - | - | - |
|
Net Income
|
-106.19 | -86.92 | -76.41 | -58.76 | -35.25 |
Supplemental
Per share data, derived & other items — not part of the income statement
in millions USD unless noted
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY |
|---|---|---|---|---|---|
|
Depreciation & Amortization
|
- | - | - | - | - |
|
EBITDA
|
-112.79 | -96.12 | -84.99 | -60.30 | -35.25 |
|
Earnings Per Share (Basic)
|
-1.76 | -1.75 | -1.93 | -1.96 | - |
|
Diluted EPS
|
-1.76 | -1.75 | -1.93 | -1.96 | - |
|
Weighted Average Shares
|
60.34 | 49.65 | 39.62 | 29.94 | - |
|
Diluted Weighted Avg Shares
|
60.34 | 49.65 | 39.62 | 29.94 | - |
|
Comprehensive Income
|
-106.56 | -87.20 | -75.80 | -58.84 | - |